2019 Q3 Form 10-Q Financial Statement
#000129913019000046 Filed on August 06, 2019
Income Statement
| Concept | 2019 Q3 | 2019 Q2 | 2018 Q2 |
|---|---|---|---|
| Revenue | $21.92M | $24.62M | $21.58M |
| YoY Change | 20.68% | 14.1% | 7.5% |
| Cost Of Revenue | $15.00M | $15.01M | $12.72M |
| YoY Change | 0.22% | 17.99% | 5.39% |
| Gross Profit | $6.914M | $9.613M | $8.862M |
| YoY Change | 116.6% | 8.47% | 10.76% |
| Gross Profit Margin | 31.55% | 39.04% | 41.07% |
| Selling, General & Admin | $20.07M | $19.08M | $14.94M |
| YoY Change | 48.57% | 27.73% | -3.68% |
| % of Gross Profit | 290.22% | 198.51% | 168.58% |
| Research & Development | $14.96M | $14.91M | $15.66M |
| YoY Change | 4.22% | -4.79% | -7.23% |
| % of Gross Profit | 216.4% | 155.1% | 176.71% |
| Depreciation & Amortization | $1.890M | $1.790M | $1.810M |
| YoY Change | 3.28% | -1.1% | -9.05% |
| % of Gross Profit | 27.34% | 18.62% | 20.42% |
| Operating Expenses | $35.03M | $33.99M | $30.61M |
| YoY Change | 25.72% | 11.06% | -5.5% |
| Operating Profit | -$28.11M | -$24.38M | -$21.75M |
| YoY Change | 13.96% | 12.12% | -10.83% |
| Interest Expense | $664.0K | $644.0K | -$600.0K |
| YoY Change | 7.79% | -207.33% | -27.71% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$345.0K | $428.0K | -$200.0K |
| YoY Change | -242.56% | -314.0% | -39.39% |
| Pretax Income | -$29.12M | -$24.60M | -$22.54M |
| YoY Change | 16.29% | 9.14% | -11.75% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$29.12M | -$24.60M | -$22.54M |
| YoY Change | 16.29% | 9.12% | -11.74% |
| Net Earnings / Revenue | -132.89% | -99.9% | -104.46% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$190.4K | -$161.0K | -$170.9K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 153.0M | 152.7M | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2019 Q3 | 2019 Q2 | 2018 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $63.78M | $80.08M | $63.50M |
| YoY Change | -48.33% | 26.11% | -38.11% |
| Cash & Equivalents | $33.08M | $30.36M | $23.06M |
| Short-Term Investments | $30.70M | $49.72M | $40.40M |
| Other Short-Term Assets | $2.700M | $2.500M | $2.000M |
| YoY Change | 35.0% | 25.0% | -42.86% |
| Inventory | $15.07M | $17.40M | $23.40M |
| Prepaid Expenses | |||
| Receivables | $9.966M | $12.12M | $7.400M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $76.94M | $98.91M | $96.40M |
| YoY Change | -46.52% | 2.6% | -27.46% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $31.62M | $33.46M | $36.10M |
| YoY Change | -8.33% | -7.32% | -10.42% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $41.00K | $41.00K | $4.500M |
| YoY Change | -4.65% | -99.09% | -4.26% |
| Total Long-Term Assets | $69.17M | $71.67M | $40.70M |
| YoY Change | 77.21% | 76.1% | -9.56% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $76.94M | $98.91M | $96.40M |
| Total Long-Term Assets | $69.17M | $71.67M | $40.70M |
| Total Assets | $146.1M | $170.6M | $137.1M |
| YoY Change | -20.12% | 24.42% | -22.93% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $8.111M | $8.011M | $4.200M |
| YoY Change | 35.95% | 90.74% | -35.38% |
| Accrued Expenses | $15.82M | $14.11M | $10.90M |
| YoY Change | 70.18% | 29.42% | -38.76% |
| Deferred Revenue | $6.379M | $6.707M | |
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | $15.50M | $15.20M | |
| YoY Change | |||
| Total Short-Term Liabilities | $50.69M | $49.45M | $22.30M |
| YoY Change | 134.16% | 121.76% | -37.54% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $14.10M |
| YoY Change | -100.0% | -100.0% | 35.58% |
| Other Long-Term Liabilities | $44.40M | $45.40M | $15.20M |
| YoY Change | 196.0% | 198.68% | -4.4% |
| Total Long-Term Liabilities | $44.40M | $45.40M | $29.30M |
| YoY Change | 51.02% | 54.95% | 11.41% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $50.69M | $49.45M | $22.30M |
| Total Long-Term Liabilities | $44.40M | $45.40M | $29.30M |
| Total Liabilities | $95.10M | $94.83M | $51.60M |
| YoY Change | 86.37% | 83.78% | -16.77% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$1.066B | -$1.037B | |
| YoY Change | 12.07% | ||
| Common Stock | $153.0K | $153.0K | |
| YoY Change | 2.68% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $51.01M | $75.75M | $85.47M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $146.1M | $170.6M | $137.1M |
| YoY Change | -20.12% | 24.42% | -22.93% |
Cashflow Statement
| Concept | 2019 Q3 | 2019 Q2 | 2018 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$29.12M | -$24.60M | -$22.54M |
| YoY Change | 16.29% | 9.12% | -11.74% |
| Depreciation, Depletion And Amortization | $1.890M | $1.790M | $1.810M |
| YoY Change | 3.28% | -1.1% | -9.05% |
| Cash From Operating Activities | -$17.26M | -$17.56M | -$14.50M |
| YoY Change | 21.72% | 21.1% | 13.19% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$830.0K | -$620.0K | -$1.360M |
| YoY Change | 730.0% | -54.41% | -60.58% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $20.49M | $8.420M | $13.55M |
| YoY Change | -155.01% | -37.86% | -134.61% |
| Cash From Investing Activities | $19.66M | $7.820M | $12.19M |
| YoY Change | -152.65% | -35.85% | -128.62% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 330.0K | 1.400M | -90.00K |
| YoY Change | -99.5% | -1655.56% | -100.14% |
| NET CHANGE | |||
| Cash From Operating Activities | -17.26M | -17.56M | -14.50M |
| Cash From Investing Activities | 19.66M | 7.820M | 12.19M |
| Cash From Financing Activities | 330.0K | 1.400M | -90.00K |
| Net Change In Cash | 2.730M | -8.340M | -2.400M |
| YoY Change | -81.8% | 247.5% | -132.0% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$17.26M | -$17.56M | -$14.50M |
| Capital Expenditures | -$830.0K | -$620.0K | -$1.360M |
| Free Cash Flow | -$16.43M | -$16.94M | -$13.14M |
| YoY Change | 16.69% | 28.92% | 40.38% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2019-06-30 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001299130 | ||
| CY2019Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
152964532 | |
| dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
| dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | ||
| dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | ||
| dei |
Entity Shell Company
EntityShellCompany
|
false | ||
| dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
| dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | ||
| dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
| dei |
Trading Symbol
TradingSymbol
|
PACB | ||
| CY2019Q2 | pacb |
Additional Liability Associated With Indemnification Obligations
AdditionalLiabilityAssociatedWithIndemnificationObligations
|
0 | |
| CY2017Q3 | pacb |
Amount Of Common Stock Preferred Stock Depository Shares Warrants Units Or Debt Securities Available In Future Public Offerings
AmountOfCommonStockPreferredStockDepositorySharesWarrantsUnitsOrDebtSecuritiesAvailableInFuturePublicOfferings
|
150000000 | |
| CY2018Q4 | pacb |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
3000 | |
| CY2019Q2 | pacb |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
21000 | |
| CY2018Q4 | pacb |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
39000 | |
| CY2019Q2 | pacb |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
4000 | |
| CY2018Q4 | pacb |
Cash Cash Equivalents And Investments Excluding Restricted Cash
CashCashEquivalentsAndInvestmentsExcludingRestrictedCash
|
102400000 | |
| CY2019Q2 | pacb |
Cash Cash Equivalents And Investments Excluding Restricted Cash
CashCashEquivalentsAndInvestmentsExcludingRestrictedCash
|
66800000 | |
| CY2017Q3 | pacb |
Common Stock Preferred Stock Depository Shares Warrants Units Or Debt Securities Available In Future Public Offerings Period From Effective Date
CommonStockPreferredStockDepositorySharesWarrantsUnitsOrDebtSecuritiesAvailableInFuturePublicOfferingsPeriodFromEffectiveDate
|
P3Y | |
| CY2019Q2 | pacb |
Debt Instrument Interest And Discount
DebtInstrumentInterestAndDiscount
|
1960000 | |
| CY2019Q2 | pacb |
Fair Value Assets Liabilities Transfer Between Levels
FairValueAssetsLiabilitiesTransferBetweenLevels
|
0 | |
| pacb |
Inventory Transferred From Property And Equipment
InventoryTransferredFromPropertyAndEquipment
|
343000 | ||
| pacb |
Inventory Transferred From Property And Equipment
InventoryTransferredFromPropertyAndEquipment
|
966000 | ||
| CY2019Q2 | pacb |
Long Term Debt Maturities Repayments Of Debt Including Interest And Principal
LongTermDebtMaturitiesRepaymentsOfDebtIncludingInterestAndPrincipal
|
17193000 | |
| pacb |
Net Cash Provided By Used In Operating Activities Excluding Restricted Cash
NetCashProvidedByUsedInOperatingActivitiesExcludingRestrictedCash
|
42900000 | ||
| pacb |
Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
|
1289000 | ||
| pacb |
Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
|
32862000 | ||
| CY2019Q2 | pacb |
Reverse Termination Fee Receivable Required Upon Termination Of Merger Agreement Under Certain Specified Circumstances
ReverseTerminationFeeReceivableRequiredUponTerminationOfMergerAgreementUnderCertainSpecifiedCircumstances
|
98000000 | |
| CY2019Q2 | pacb |
Share Based Compensation Arrangements By Share Based Payment Awards Number Of Active Plans
ShareBasedCompensationArrangementsByShareBasedPaymentAwardsNumberOfActivePlans
|
3 | |
| pacb |
Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
|
492000 | ||
| pacb |
Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
|
1427000 | ||
| CY2018Q4 | pacb |
Weighted Average Market Yield Percentage
WeightedAverageMarketYieldPercentage
|
0.096 | |
| CY2019Q2 | pacb |
Weighted Average Market Yield Percentage
WeightedAverageMarketYieldPercentage
|
0.088 | |
| CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6736000 | |
| CY2019Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8011000 | |
| CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8595000 | |
| CY2019Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
12123000 | |
| CY2018Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
12823000 | |
| CY2019Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
14107000 | |
| CY2018Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-36000 | |
| CY2019Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
17000 | |
| CY2018Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1096053000 | |
| CY2019Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1112610000 | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
10506000 | ||
| CY2018Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5224000 | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
8470000 | ||
| CY2019Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4089000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
10506000 | ||
| CY2018Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5224000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8470000 | ||
| CY2019Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4089000 | |
| us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
486000 | ||
| us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
574000 | ||
| CY2018Q4 | us-gaap |
Assets
Assets
|
170275000 | |
| CY2019Q2 | us-gaap |
Assets
Assets
|
170582000 | |
| CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
131659000 | |
| CY2019Q2 | us-gaap |
Assets Current
AssetsCurrent
|
98909000 | |
| CY2018Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
106854000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
102354000 | |
| CY2019Q2 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
66844000 | |
| CY2018Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
102390000 | |
| CY2019Q2 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
66827000 | |
| CY2019Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
49720000 | |
| CY2019Q2 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
49720000 | |
| CY2019Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.16 | |
| CY2018Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
16000 | |
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:13.5pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Basis of Presentation and Consolidation </font> </p> <p style="margin:4.5pt 0pt 0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">In the opinion of management, our accompanying unaudited Condensed Consolidated Financial Statements (“Financial Statements”) have been prepared on a consistent basis with our December 31, 2018 audited Consolidated Financial Statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and, as permitted by such rules and regulations, omit certain information and footnote disclosures necessary to present the statements in accordance with </font><font style="display: inline;color:#000000;font-size:10pt;">accounting principles generally accepted in the United States</font><font style="display: inline;font-size:10pt;"> (“U.S. GAAP”). These Financial Statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018. The results of operations for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the entire year or any future periods.</font> </p> <p style="margin:4.5pt 0pt 0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">The consolidated financial statements include the accounts of Pacific Biosciences and our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated. </font> </p> <p><font size="1"> </font></p> </div> </div> | ||
| CY2018Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
23058000 | |
| CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
18844000 | |
| CY2019Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
30358000 | |
| CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21007000 | |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
27558000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
23344000 | |
| CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
34358000 | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
6551000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
11014000 | ||
| CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
150244000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
152959000 | |
| CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
150244000 | |
| CY2019Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
152959000 | |
| CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
150000 | |
| CY2019Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
153000 | |
| CY2019Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-24585000 | |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:4.5pt 0pt 0pt;text-indent:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Concentration and Other Risks </font> </p> <p style="margin:4.5pt 0pt 0pt;text-indent:31.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">For the three and six months ended June 30, 2019, </font><font style="display: inline;font-size:10pt;">one</font><font style="display: inline;font-size:10pt;"> of our customers, Gene Company Limited, accounted for approximately </font><font style="display: inline;font-size:10pt;">23%</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">20%</font><font style="display: inline;font-size:10pt;"> of our total revenue, respectively. For the three and six months ended June 30, 2018, </font><font style="display: inline;font-size:10pt;">one</font><font style="display: inline;font-size:10pt;"> of our customers, Gene Company Limited, accounted for approximately </font><font style="display: inline;font-size:10pt;">33%</font><font style="display: inline;font-size:10pt;"> and </font><font style="display: inline;font-size:10pt;">31%</font><font style="display: inline;font-size:10pt;"> of our total revenue, respectively. Gene Company Limited is our distributor in China. </font> </p> <p><font size="1"> </font></p> </div> </div> | ||
| CY2018Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
6537000 | |
| CY2019Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
6707000 | |
| CY2018Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
890000 | |
| CY2019Q2 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1454000 | |
| CY2019Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
15008000 | |
| CY2019Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
0 | |
| CY2018Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
13765000 | |
| us-gaap |
Depreciation
Depreciation
|
3611000 | ||
| us-gaap |
Depreciation
Depreciation
|
3586000 | ||
| CY2018Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
16000 | |
| CY2018Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
16000 | |
| us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
143000 | ||
| us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
16000 | ||
| CY2019Q2 | us-gaap |
Gross Profit
GrossProfit
|
9613000 | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-4765000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
685000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-5987000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3528000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1683000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1284000 | ||
| us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-75000 | ||
| us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-734000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
560000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
40000 | ||
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-208000 | ||
| us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
-701000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-337000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-388000 | ||
| CY2019Q2 | us-gaap |
Interest Expense
InterestExpense
|
644000 | |
| CY2018Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
4315000 | |
| CY2019Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
4517000 | |
| CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
17878000 | |
| CY2019Q2 | us-gaap |
Inventory Net
InventoryNet
|
17404000 | |
| CY2018Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
6222000 | |
| CY2019Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
7988000 | |
| CY2018Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
7341000 | |
| CY2019Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
4899000 | |
| us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
194000 | ||
| us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
677000 | ||
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
64691000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
31518000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
7704000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
7488000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
7305000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
7150000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
3526000 | |
| CY2019Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
17139000 | |
| CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
56214000 | |
| CY2019Q2 | us-gaap |
Liabilities
Liabilities
|
94828000 | |
| CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
170275000 | |
| CY2019Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
170582000 | |
| CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
26884000 | |
| CY2019Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
49453000 | |
| CY2018Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
16000 | |
| CY2019Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
15233000 | |
| CY2019Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
16491000 | |
| CY2019Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
702000 | |
| CY2018Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
14659000 | |
| CY2019Q2 | us-gaap |
Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
|
300000 | |
| us-gaap |
Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
|
5 | ||
| CY2019Q1 | us-gaap |
Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
|
5 | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
35379000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8090000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
4442000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
45796000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-33270000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-42872000 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-46719000 | ||
| CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22540000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-54920000 | ||
| CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24596000 | |
| us-gaap |
New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
|
189000 | ||
| CY2019Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
15233000 | |
| CY2019Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
33993000 | |
| CY2019Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24380000 | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
3100000 | ||
| CY2019Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1600000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
49200000 | |
| CY2019Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
47552000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3400000 | |
| CY2019Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3631000 | |
| CY2019Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
45800000 | |
| CY2019Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
43921000 | |
| us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
3500000 | ||
| CY2019Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
35500000 | |
| CY2019Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
34175000 | |
| CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
43000 | |
| CY2019Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
41000 | |
| us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
16000 | ||
| CY2018Q2 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
22000 | |
| us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
53000 | ||
| CY2019Q2 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
11000 | |
| CY2018Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
788000 | |
| CY2019Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
1764000 | |
| CY2019Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
428000 | |
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
44500000 | ||
| us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
36748000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1700000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1866000 | ||
| CY2019Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2019Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2019Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2019Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
| CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2832000 | |
| CY2019Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2538000 | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2517000 | ||
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
8090000 | ||
| us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
48200000 | ||
| us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
84410000 | ||
| us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
2442000 | ||
| CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34073000 | |
| CY2019Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
33457000 | |
| CY2019Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14910000 | |
| CY2018Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
4500000 | |
| CY2019Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
4000000 | |
| CY2015Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
4500000 | |
| CY2018Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
4500000 | |
| CY2019Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
4000000 | |
| CY2019Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
4000000 | |
| CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-982106000 | |
| CY2019Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1037026000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
40940000 | ||
| CY2018Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
21578000 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
41046000 | ||
| CY2019Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
24621000 | |
| CY2019Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
19083000 | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
10506000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8470000 | ||
| CY2018Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
83510000 | |
| CY2019Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
36486000 | |
| CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
86103000 | |
| CY2018Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
102738000 | |
| CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
85474000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
114061000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
94850000 | |
| CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75754000 | |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
32862000 | ||
| us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2517000 | ||
| CY2018Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
30000 | |
| us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
8090000 | ||
| CY2019Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1400000 | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:13.5pt 0pt 0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;font-size:10pt;">Use of Estimates </font> </p> <p style="margin:4.5pt 0pt 0pt;text-indent:24.5pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes to the financial statements. Our estimates include, but are not limited to, the valuation of inventory, the determination of stand-alone selling prices for revenue recognition, the valuation of a financing derivative and long-term notes, the valuation and recognition of share-based compensation, the expected renewal period for service contracts, the useful lives assigned to long-lived assets, the computation of provisions for income taxes and the determination of the internal borrowing rate used in calculating the operating lease right-of-use assets and operating lease liabilities. Actual results could differ materially from these estimates. </font> </p> <p><font size="1"> </font></p> </div> </div> | ||
| CY2019Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
152776000 |
